Many of the faculty members in the Department of Pharmacology utilize the human genome sequence and molecular structure to define how and where pharmacological processes occur. Knowledge of the human genome allows our faculty to define the target of pharmacologically important molecules. Defining the molecular structure of the target protein allows pharmacological mechanisms of molecules to be defined. The centers and facilities that aid in this research include the DNA Array Facility, the Center for Computational Pharmacology, the Mass Spectrometry Center, the Nuclear Magnetic Resonance Center, and the X-ray Crystallography Center.
Nuclear Magnetic Resonance Center
The Nuclear Magnetic Resonance (NMR) Center is used to study the three-dimensional structure of biological molecules, including proteins, nucleic acids, carbohydrates and lipids. The research focuses primarily on protein domains involved in endocytosis, signal transduction, viral replication, and neurotransmission.
The first three-dimensional structure of an Eps15 homology domain bound to an endocytic peptide signal has been solved in the NMR Center. It reveals how the Eps15 protein contributes to the regulation of cell growth. The structure of a domain of the EEA1 protein bound to a phospholipid has been determined, revealing how membrane lipids are specifically recognized. Proteins that package viral DNA and bind alcohol and neurotransmitters are also being characterized. Understanding the structural mechanisms of these proteins will inform the design of new therapeutic agents for cancer, Parkinson's disease, and alcohol toxicity and addiction.
Mass Spectrometry Center
For the past three decades, the Department of Pharmacology at the University of Colorado School of Medicine has maintained a presence in the advancement of mass spectrometric techniques to solve difficult problems in the pharmacological sciences.
In the past, this has taken form in the elucidation of chemical structures of biologically active lipids derived from arachidonic acid and delineation of the biochemical mechanisms involved in the metabolism of these important eicosanoids. Mass spectrometry has also been a central tool to expand our understanding of the complexities of eicosanoid biosynthesis within cells in tissues.However, with the post-genomic era, mass spectrometry has now emerged as a central technique that permits precise identification of proteins expressed within cells. Investigators in the Department of Pharmacology and colleagues in the Department of Pharmaceutical Sciences (School of Pharmacy) have installed the new generation of mass spectrometric instruments, including:
A matrix-assisted laser desorption, time-of-flight mass spectrometer, capable of direct analysis of proteins and peptides.
Tandem quadruple mass spectrometers for direct liquid chromatography-tandem mass spectrometry.
Ion trap mass spectrometers (MSn capabilities) to address the identification of expressed, as well as to assess postranslational modifications of proteins; (events that are not programmed into the genome.)
One example of current capability is the study of the covalent binding of leukotriene A4 with leukotriene A4 hydrolase and the isolation of a specific peptide containing the covalently linked leukotriene A4 (1). Detailed mass spectrometric investigation permitted the sequencing of the peptide and the assignment of the covalent attachment site as tyrosine-383 close to the active site of leukotriene A4 hydrolase. Such detailed biochemical information provides some insight into the enzymatic mechanism of LTA, hydrolase as well as a broader understanding of potential agents which may interfere with the production of leukotriene B, and thus, pharmacologically control this enzyme.
X-ray Crystallography Center
The Biomolecular X-ray Crystallography Center provides the facilities to the UCD community for production of crystals of macromolecules and determination of high resolution 3-dimensional structures using X-ray crystallography. For example, whether genes are regulated directly by proteins in transcription complexes or indirectly through signals generated by bacterial quorum sensing systems, structural analysis is an essential and illustrative approach to understanding function and developing therapeutic agents. Users of the X-ray Crystallography Center are also interested in the way that molecular recognition is involved in a variety of processes.
Current projects include the study of chromosomal protein-DNA complexes, structural studies of tumor viruses and viral protein interactions, DNA modification enzymes, and proteins involved in bacterial pathogenesis. Learning more about the structure and function of the molecules active in these systems will advance our understanding of fundamental molecular processes in the cell and aid in fighting human disease.
Churchill, Mair E. A., Professor
Ph.D., 1987, Johns Hopkins Univ.
Structure and mechanism in gene regulation; biophysical and structural studies of protein-nucleic acid and protein-protein complexes in chromatin and bacterial pathogenesis.
Jones, David N. M., Associate Professor
Ph.D., 1989, Univ. of Cambridge
Molecular mechanism of alcohols and anesthetic actions; structure and function of biomolecules; NMR spectroscopy, x-ray crystallography, biophysics and molecular biology.
Kutateladze, Tatiana G., Professor
Ph.D., 1988, Moscow State Univ.
Epigenetics, phosphoinositide signaling, structural biology, NMR and crystal structures of proteins implicated in cancer, structure based drug design.
Murphy, Robert C., University Distinguished Professor
Ph.D., 1970, Massachusetts Institute of Technology
Pharmacology and biochemistry of leukotrienes and bioactive lipids, lipid mediators of cellular response using biochemical mass spectrometry.